Interleukin-17A as a Possible Treatment Target in Long-Term Lung Diseases

Interleukin-17A (IL-17A) is identified as a significant factor in various chronic respiratory diseases.

• IL-17A is involved in immune responses related to allergy and inflammation.
• The cytokine is linked to the progression of conditions such as Idiopathic Pulmonary Fibrosis (IPF), Chronic Obstructive Pulmonary Disease (COPD), asthma, pneumonia, and lung cancer.
• Increased levels of IL-17A may contribute to the severity of these respiratory diseases.
• Conversely, the absence of IL-17A could lead to a reduction in disease severity.
• The review highlights IL-17A as a potential target for therapeutic intervention in chronic respiratory conditions.

Simplified